[1]
“Artificial Intelligence–Driven Design of Selective Apoptosis Re-activators Targeting Unendurable Cancer Proteins”, WJMS, vol. 3, no. 1, pp. 24–33, Jan. 2026, doi: 10.65336/WJMS.2026.3105.